Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Current Trends in Antibody Drug Conjugates

Priyaranjan Pattanaik's Biography



Priyaranjan Pattanaik, Associate Research Director, Syngene International Ltd

Dr Priyaranjan is a structural biologist by training. After completing PhD at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bangalore, he conducted post-doctoral research at Case Western reserve University, USA. He joined Syngene in 2008 and for the last several years he has led biotherapeutics and ADC discovery research at Syngene. Dr Priyaranjan is responsible for establishing the ADC platform in Syngene which has seen successful collaborations with multiple global pharma companies.

Priyaranjan Pattanaik Image

Changing Landscape of Antibody Drug Conjugates: A CRO Perspective

Monday, 2 March 2015 at 16:55

Add to Calendar ▼2015-03-02 16:55:002015-03-02 17:55:00Europe/LondonChanging Landscape of Antibody Drug Conjugates: A CRO PerspectiveCurrent Trends in Antibody Drug Conjugates in Bangalore, IndiaBangalore, IndiaSELECTBIOenquiries@selectbiosciences.com


Add to Calendar ▼2015-03-02 00:00:002015-03-03 00:00:00Europe/LondonCurrent Trends in Antibody Drug ConjugatesCurrent Trends in Antibody Drug Conjugates in Bangalore, IndiaBangalore, IndiaSELECTBIOenquiries@selectbiosciences.com